Histogen Correlations

HSTO Stock  USD 0.02  0.01  25.65%   
The current 90-days correlation between Histogen and Eliem Therapeutics is -0.01 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Histogen Correlation With Market

Good diversification

The correlation between Histogen and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.

Moving against Histogen Stock

  0.73RNXT RenovoRxPairCorr
  0.55MDGL Madrigal PharmaceuticalsPairCorr
  0.43CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.39BAC Bank of America Aggressive PushPairCorr
  0.39JPM JPMorgan Chase Sell-off TrendPairCorr
  0.31PG Procter GamblePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SCPHELYM
MCRBELYM
MCRBSCPH
LUMOMIST
  
High negative correlations   
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTELYM
MISTSCPH
MCRBMIST

Risk-Adjusted Indicators

There is a big difference between Histogen Stock performing well and Histogen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Histogen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Histogen Corporate Management

Stephen HillVP ControllerProfile
Steven MentoInterim ChairmanProfile
Thomas HubkaDirector SecProfile
Gail NaughtonFounder AdvisorProfile